These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32268107)

  • 1. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition.
    Gorman J; Chuang GY; Lai YT; Shen CH; Boyington JC; Druz A; Geng H; Louder MK; McKee K; Rawi R; Verardi R; Yang Y; Zhang B; Doria-Rose NA; Lin B; Moore PL; Morris L; Shapiro L; Mascola JR; Kwong PD
    Cell Rep; 2020 Apr; 31(1):107488. PubMed ID: 32268107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.
    Wang H; Gristick HB; Scharf L; West AP; Galimidi RP; Seaman MS; Freund NT; Nussenzweig MC; Bjorkman PJ
    Elife; 2017 May; 6():. PubMed ID: 28548638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
    Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM
    Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.
    Doria-Rose NA; Bhiman JN; Roark RS; Schramm CA; Gorman J; Chuang GY; Pancera M; Cale EM; Ernandes MJ; Louder MK; Asokan M; Bailer RT; Druz A; Fraschilla IR; Garrett NJ; Jarosinski M; Lynch RM; McKee K; O'Dell S; Pegu A; Schmidt SD; Staupe RP; Sutton MS; Wang K; Wibmer CK; Haynes BF; Abdool-Karim S; Shapiro L; Kwong PD; Moore PL; Morris L; Mascola JR
    J Virol; 2016 Jan; 90(1):76-91. PubMed ID: 26468542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
    Reh L; Magnus C; Kadelka C; Kühnert D; Uhr T; Weber J; Morris L; Moore PL; Trkola A
    PLoS Pathog; 2018 Jan; 14(1):e1006825. PubMed ID: 29370298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro affinity maturation of broader and more-potent variants of the HIV-1-neutralizing antibody CAP256-VRC26.25.
    Yin Y; Quinlan BD; Ou T; Guo Y; He W; Farzan M
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34261793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure.
    Lee JH; Andrabi R; Su CY; Yasmeen A; Julien JP; Kong L; Wu NC; McBride R; Sok D; Pauthner M; Cottrell CA; Nieusma T; Blattner C; Paulson JC; Klasse PJ; Wilson IA; Burton DR; Ward AB
    Immunity; 2017 Apr; 46(4):690-702. PubMed ID: 28423342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.
    Guzzo C; Zhang P; Liu Q; Kwon AL; Uddin F; Wells AI; Schmeisser H; Cimbro R; Huang J; Doria-Rose N; Schmidt SD; Dolan MA; Connors M; Mascola JR; Lusso P
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.
    Davis-Gardner ME; Alfant B; Weber JA; Gardner MR; Farzan M
    mBio; 2020 Jan; 11(1):. PubMed ID: 31937648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design.
    Gorman J; Soto C; Yang MM; Davenport TM; Guttman M; Bailer RT; Chambers M; Chuang GY; DeKosky BJ; Doria-Rose NA; Druz A; Ernandes MJ; Georgiev IS; Jarosinski MC; Joyce MG; Lemmin TM; Leung S; Louder MK; McDaniel JR; Narpala S; Pancera M; Stuckey J; Wu X; Yang Y; Zhang B; Zhou T; ; Mullikin JC; Baxa U; Georgiou G; McDermott AB; Bonsignori M; Haynes BF; Moore PL; Morris L; Lee KK; Shapiro L; Mascola JR; Kwong PD
    Nat Struct Mol Biol; 2016 Jan; 23(1):81-90. PubMed ID: 26689967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
    van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design.
    Andrabi R; Voss JE; Liang CH; Briney B; McCoy LE; Wu CY; Wong CH; Poignard P; Burton DR
    Immunity; 2015 Nov; 43(5):959-73. PubMed ID: 26588781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
    Andrabi R; Su CY; Liang CH; Shivatare SS; Briney B; Voss JE; Nawazi SK; Wu CY; Wong CH; Burton DR
    Immunity; 2017 Sep; 47(3):524-537.e3. PubMed ID: 28916265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.
    Gift SK; Leaman DP; Zhang L; Kim AS; Zwick MB
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
    Yang Z; Dam KA; Gershoni JM; Zolla-Pazner S; Bjorkman PJ
    J Virol; 2022 Dec; 96(24):e0108222. PubMed ID: 36448805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Anatomy of the Trimer Apex Reveals Key Hydrophobic Constraints That Maintain the HIV-1 Envelope Spike in a Closed State.
    Zhang P; Kwon AL; Guzzo C; Liu Q; Schmeisser H; Miao H; Lin Y; Cimbro R; Huang J; Connors M; Schmidt SD; Dolan MA; Armstrong AA; Lusso P
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.
    Ahmed S; Shrivastava T; Kumar R; Kumar M; Banerjee M; Kumar N; Bansal M; Das S; Samal S
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129733. PubMed ID: 32949621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies.
    Kesavardhana S; Das R; Citron M; Datta R; Ecto L; Srilatha NS; DiStefano D; Swoyer R; Joyce JG; Dutta S; LaBranche CC; Montefiori DC; Flynn JA; Varadarajan R
    J Biol Chem; 2017 Jan; 292(1):278-291. PubMed ID: 27879316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.